Product Information

METHOTREXATE 2.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1689 per EA under NDC 16729048601. Its NADAC has been published 319 times since Oct 14, 2020.

FDA first approved this application on Jan 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHOTREXATE 2.5 MG TABLET

Methotrexate
$0.1689per EA

Strength

2.5 mg/1

NDC

16729048601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA213343

FDA Approved

1/24/2020

TE Code

AB

On Market Since

8/24/2020

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price Statistics

The NADAC for METHOTREXATE 2.5 MG TABLET has been published 319 times since Oct 14, 2020, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1689 per EA
All-time high$0.5061 (Mar 10, 2021)
All-time low$0.1507 (May 22, 2024)
52-week high$0.1689
52-week low$0.1530
Median price$0.1944
Average price$0.2336
Largest weekly change+41.4% (Jun 19, 2024)
Weeks tracked319
Tracking sinceOct 14, 2020

Price History

1W

+3.5%

1M

+7.1%

3M

+7.9%

6M

+3.0%

1Y

+10.4%

3Y

-25.5%

5Y

-42.2%

All

-58.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHOTREXATE 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 2.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1689 per EA (NDC 16729048601), effective Nov 18, 2026.

How has the price of METHOTREXATE 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHOTREXATE 2.5 MG TABLET has declined 58.1%. It has been tracked across 319 weekly CMS publications since Oct 14, 2020.

What are the highest and lowest recorded NADAC prices for METHOTREXATE 2.5 MG TABLET?

Since Oct 14, 2020, the NADAC for METHOTREXATE 2.5 MG TABLET has ranged from a low of $0.1507 (May 22, 2024) to a high of $0.5061 (Mar 10, 2021), with a median of $0.1944 per EA.

Are there cheaper alternatives to METHOTREXATE 2.5 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHOTREXATE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHOTREXATE 2.5 MG TABLET?

METHOTREXATE 2.5 MG TABLET (NDC 16729048601) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.